ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 688,67
-0,05%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) Actualités

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateHeureSourceTitreSymboleSociété
24/05/202422h00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
09/05/202422h05GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
09/05/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
09/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
08/05/202414h00GlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
07/05/202414h00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
24/04/202416h01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
08/04/202422h05GlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
02/04/202414h00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
08/03/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/02/202416h00GlobeNewswire Inc.Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers SymposiumNASDAQ:CUECue Biopharma Inc
06/02/202414h00GlobeNewswire Inc.Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
22/11/202314h00GlobeNewswire Inc.Cue Biopharma to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:CUECue Biopharma Inc
09/11/202322h05GlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
07/11/202314h00GlobeNewswire Inc.Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in NovemberNASDAQ:CUECue Biopharma Inc
03/11/202317h00GlobeNewswire Inc.Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023NASDAQ:CUECue Biopharma Inc
27/09/202315h05GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:CUECue Biopharma Inc
26/09/202314h00GlobeNewswire Inc.Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®NASDAQ:CUECue Biopharma Inc
09/08/202322h10GlobeNewswire Inc.Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
14/06/202314h00GlobeNewswire Inc.Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual MeetingNASDAQ:CUECue Biopharma Inc
09/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CUECue Biopharma Inc
07/06/202314h00GlobeNewswire Inc.Cue Biopharma to Host Investor CallNASDAQ:CUECue Biopharma Inc
05/06/202314h00GlobeNewswire Inc.Cue Biopharma to Present at the Jefferies 2023 Global Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
30/05/202312h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CUECue Biopharma Inc
25/05/202323h00GlobeNewswire Inc.Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
15/05/202314h00GlobeNewswire Inc.Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
09/05/202322h35GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
09/05/202322h10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CUECue Biopharma Inc
08/05/202314h00GlobeNewswire Inc.Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
28/04/202322h18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Dernières Valeurs Consultées

NASDAQ
BLBD
Blue Bird
LSE
64EU
Gracech.crd 1as
ASX
ILCDO2
AMEX
MAYU
AllianzIM US Equity Buff...
NYSE
NCV
Virtus Convertible and I...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés